Home/Filings/4/0001848474-25-000007
4//SEC Filing

Fox Lynne P. 4

Accession 0001848474-25-000007

CIK 0001823608other

Filed

Nov 2, 7:00 PM ET

Accepted

Nov 3, 8:06 PM ET

Size

22.3 KB

Accession

0001848474-25-000007

Insider Transaction Report

Form 4
Period: 2025-08-07
Fox Lynne P.
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2025-10-30$12.00/sh+4,820$57,84026,734 total
  • Exercise/Conversion

    Common Stock

    2025-10-30$13.75/sh+7,020$96,52531,373 total
  • Exercise/Conversion

    Common Stock

    2025-10-30$14.65/sh+6,560$96,10434,465 total
  • Sale

    Common Stock

    2025-10-31$27.34/sh8,949$244,62422,276 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-10-306,5600 total
    Exercise: $14.65From: 2018-01-01Exp: 2028-01-01Common Stock (6,560 underlying)
  • Tax Payment

    Common Stock

    2025-10-30$27.56/sh3,468$95,56927,905 total
  • Award

    Common Stock

    2025-11-01+2,56824,844 total
  • Tax Payment

    Common Stock

    2025-10-30$27.56/sh2,381$65,61424,353 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-10-307,0200 total
    Exercise: $13.75From: 2017-01-01Exp: 2027-01-01Common Stock (7,020 underlying)
  • Sale

    Common Stock

    2025-08-07$27.49/sh300$8,24721,914 total
  • Tax Payment

    Common Stock

    2025-10-30$27.56/sh3,240$89,28631,225 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-10-304,8200 total
    Exercise: $12.00From: 2016-01-01Exp: 2026-01-01Common Stock (4,820 underlying)
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.06 - $27.63 . The reporting person undertakes to provide to AMAL, any security holder of AMAL, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
  • [F2]The reported transaction involved the reporting person's receipt of a grant of 2,568 restricted stock units. The restricted stock units vest immediately upon grant, in consideration of the Company's termination of the stock option program and the Director's early exercise of all outstanding and vested stock options on October 30, 2025.

Issuer

Amalgamated Financial Corp.

CIK 0001823608

Entity typeother

Related Parties

1
  • filerCIK 0001848474

Filing Metadata

Form type
4
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 8:06 PM ET
Size
22.3 KB